Medical Care

Global Ex Vivo Skin Explants Market Research Report 2026

This report delivers a comprehensive overview of the global Ex Vivo Skin Explants market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Ex Vivo Skin Explants. The Ex Vivo Skin Explants market size, estimates, and forecasts are provided in terms of revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Ex Vivo Skin Explants market comprehensively. Regional market sizes by Type, by Application, , and by player are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Ex Vivo Skin Explants manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation
By Company
Genoskin
MatTek Life Sciences
Creative Bioarray
EpiSkin
Reprocell
Alcyomics
Epistem
QIMA Life Sciences
Extherid Biosciences
Perfectus Biomed
Xenometrix
Syntivia
Creative Biolabs
Segment by Type
Human Skin Explants
Animal Skin Explants
Segment by Application
Pharmaceutical
Cosmetic
Others
By Region
North America
U.S.
Canada
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia & New Zealand
Rest of Asia
Europe
Germany
France
U.K.
Italy
Ireland
Russia
Rest of Europe
Latin America
Mexico
Brazil
Argentina
Rest of Latin America
Middle East & Africa
Israel
United Arab Emirates (UAE)
Saudi Arabia
Rest of MEA
Chapter Outline
Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
Chapter 2: Summarizes global and regional market size and outlines market dynamics and recent developments, including key drivers, restraints, challenges and risks for industry participants, and relevant policy analysis.
Chapter 3: Provides a detailed view of the competitive landscape for Ex Vivo Skin Explants companies, covering revenue share, development plans, and mergers and acquisitions.
Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify blue-ocean opportunities.
Chapter 5: Analyzes segments by Application, detailing the size and growth potential of each downstream segment to help readers identify blue-ocean opportunities.
Chapter 6–10: Regional deep dives (North America, Europe, Asia Pacific, Latin America, Middle East & Africa) broken down by country. Each chapter quantifies market size and growth potential by region and key countries, and outlines market development, outlook, addressable space, and capacity.
Chapter 11: Profiles key players, presenting essential information on leading companies, including product/ service offerings, revenue, gross margin, product introductions/portfolios, recent developments, etc.
Chapter 12: Key findings and conclusions of the report.
1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Ex Vivo Skin Explants Market Size Growth Rate by Type: 2021 vs 2025 vs 2032
1.2.2 Human Skin Explants
1.2.3 Animal Skin Explants
1.3 Market by Application
1.3.1 Global Ex Vivo Skin Explants Market Growth by Application: 2021 vs 2025 vs 2032
1.3.2 Pharmaceutical
1.3.3 Cosmetic
1.3.4 Others
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Global Growth Trends
2.1 Global Ex Vivo Skin Explants Market Perspective (2021–2032)
2.2 Global Ex Vivo Skin Explants Growth Trends by Region
2.2.1 Global Ex Vivo Skin Explants Market Size by Region: 2021 vs 2025 vs 2032
2.2.2 Ex Vivo Skin Explants Historic Market Size by Region (2021–2026)
2.2.3 Ex Vivo Skin Explants Forecasted Market Size by Region (2027–2032)
2.3 Ex Vivo Skin Explants Market Dynamics
2.3.1 Ex Vivo Skin Explants Industry Trends
2.3.2 Ex Vivo Skin Explants Market Drivers
2.3.3 Ex Vivo Skin Explants Market Challenges
2.3.4 Ex Vivo Skin Explants Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Ex Vivo Skin Explants Players by Revenue
3.1.1 Global Top Ex Vivo Skin Explants Players by Revenue (2021–2026)
3.1.2 Global Ex Vivo Skin Explants Revenue Market Share by Players (2021–2026)
3.2 Global Top Ex Vivo Skin Explants Players Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
3.3 Global Key Players Ranking by Ex Vivo Skin Explants Revenue
3.4 Global Ex Vivo Skin Explants Market Concentration Ratio
3.4.1 Global Ex Vivo Skin Explants Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Ex Vivo Skin Explants Revenue in 2025
3.5 Global Key Players of Ex Vivo Skin Explants Head Offices and Areas Served
3.6 Global Key Players of Ex Vivo Skin Explants, Products and Applications
3.7 Global Key Players of Ex Vivo Skin Explants, Date of General Availability (GA)
3.8 Mergers and Acquisitions, Expansion Plans
4 Ex Vivo Skin Explants Breakdown Data by Type
4.1 Global Ex Vivo Skin Explants Historic Market Size by Type (2021–2026)
4.2 Global Ex Vivo Skin Explants Forecasted Market Size by Type (2027–2032)
5 Ex Vivo Skin Explants Breakdown Data by Application
5.1 Global Ex Vivo Skin Explants Historic Market Size by Application (2021–2026)
5.2 Global Ex Vivo Skin Explants Forecasted Market Size by Application (2027–2032)
6 North America
6.1 North America Ex Vivo Skin Explants Market Size (2021–2032)
6.2 North America Ex Vivo Skin Explants Market Growth Rate by Country: 2021 vs 2025 vs 2032
6.3 North America Ex Vivo Skin Explants Market Size by Country (2021–2026)
6.4 North America Ex Vivo Skin Explants Market Size by Country (2027–2032)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Ex Vivo Skin Explants Market Size (2021–2032)
7.2 Europe Ex Vivo Skin Explants Market Growth Rate by Country: 2021 vs 2025 vs 2032
7.3 Europe Ex Vivo Skin Explants Market Size by Country (2021–2026)
7.4 Europe Ex Vivo Skin Explants Market Size by Country (2027–2032)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Ireland
8 Asia-Pacific
8.1 Asia-Pacific Ex Vivo Skin Explants Market Size (2021–2032)
8.2 Asia-Pacific Ex Vivo Skin Explants Market Growth Rate by Region: 2021 vs 2025 vs 2032
8.3 Asia-Pacific Ex Vivo Skin Explants Market Size by Region (2021–2026)
8.4 Asia-Pacific Ex Vivo Skin Explants Market Size by Region (2027–2032)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia & New Zealand
9 Latin America
9.1 Latin America Ex Vivo Skin Explants Market Size (2021–2032)
9.2 Latin America Ex Vivo Skin Explants Market Growth Rate by Country: 2021 vs 2025 vs 2032
9.3 Latin America Ex Vivo Skin Explants Market Size by Country (2021–2026)
9.4 Latin America Ex Vivo Skin Explants Market Size by Country (2027–2032)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Ex Vivo Skin Explants Market Size (2021–2032)
10.2 Middle East & Africa Ex Vivo Skin Explants Market Growth Rate by Country: 2021 vs 2025 vs 2032
10.3 Middle East & Africa Ex Vivo Skin Explants Market Size by Country (2021–2026)
10.4 Middle East & Africa Ex Vivo Skin Explants Market Size by Country (2027–2032)
10.5 Israel
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Genoskin
11.1.1 Genoskin Company Details
11.1.2 Genoskin Business Overview
11.1.3 Genoskin Ex Vivo Skin Explants Introduction
11.1.4 Genoskin Revenue in Ex Vivo Skin Explants Business (2021–2026)
11.1.5 Genoskin Recent Development
11.2 MatTek Life Sciences
11.2.1 MatTek Life Sciences Company Details
11.2.2 MatTek Life Sciences Business Overview
11.2.3 MatTek Life Sciences Ex Vivo Skin Explants Introduction
11.2.4 MatTek Life Sciences Revenue in Ex Vivo Skin Explants Business (2021–2026)
11.2.5 MatTek Life Sciences Recent Development
11.3 Creative Bioarray
11.3.1 Creative Bioarray Company Details
11.3.2 Creative Bioarray Business Overview
11.3.3 Creative Bioarray Ex Vivo Skin Explants Introduction
11.3.4 Creative Bioarray Revenue in Ex Vivo Skin Explants Business (2021–2026)
11.3.5 Creative Bioarray Recent Development
11.4 EpiSkin
11.4.1 EpiSkin Company Details
11.4.2 EpiSkin Business Overview
11.4.3 EpiSkin Ex Vivo Skin Explants Introduction
11.4.4 EpiSkin Revenue in Ex Vivo Skin Explants Business (2021–2026)
11.4.5 EpiSkin Recent Development
11.5 Reprocell
11.5.1 Reprocell Company Details
11.5.2 Reprocell Business Overview
11.5.3 Reprocell Ex Vivo Skin Explants Introduction
11.5.4 Reprocell Revenue in Ex Vivo Skin Explants Business (2021–2026)
11.5.5 Reprocell Recent Development
11.6 Alcyomics
11.6.1 Alcyomics Company Details
11.6.2 Alcyomics Business Overview
11.6.3 Alcyomics Ex Vivo Skin Explants Introduction
11.6.4 Alcyomics Revenue in Ex Vivo Skin Explants Business (2021–2026)
11.6.5 Alcyomics Recent Development
11.7 Epistem
11.7.1 Epistem Company Details
11.7.2 Epistem Business Overview
11.7.3 Epistem Ex Vivo Skin Explants Introduction
11.7.4 Epistem Revenue in Ex Vivo Skin Explants Business (2021–2026)
11.7.5 Epistem Recent Development
11.8 QIMA Life Sciences
11.8.1 QIMA Life Sciences Company Details
11.8.2 QIMA Life Sciences Business Overview
11.8.3 QIMA Life Sciences Ex Vivo Skin Explants Introduction
11.8.4 QIMA Life Sciences Revenue in Ex Vivo Skin Explants Business (2021–2026)
11.8.5 QIMA Life Sciences Recent Development
11.9 Extherid Biosciences
11.9.1 Extherid Biosciences Company Details
11.9.2 Extherid Biosciences Business Overview
11.9.3 Extherid Biosciences Ex Vivo Skin Explants Introduction
11.9.4 Extherid Biosciences Revenue in Ex Vivo Skin Explants Business (2021–2026)
11.9.5 Extherid Biosciences Recent Development
11.10 Perfectus Biomed
11.10.1 Perfectus Biomed Company Details
11.10.2 Perfectus Biomed Business Overview
11.10.3 Perfectus Biomed Ex Vivo Skin Explants Introduction
11.10.4 Perfectus Biomed Revenue in Ex Vivo Skin Explants Business (2021–2026)
11.10.5 Perfectus Biomed Recent Development
11.11 Xenometrix
11.11.1 Xenometrix Company Details
11.11.2 Xenometrix Business Overview
11.11.3 Xenometrix Ex Vivo Skin Explants Introduction
11.11.4 Xenometrix Revenue in Ex Vivo Skin Explants Business (2021–2026)
11.11.5 Xenometrix Recent Development
11.12 Syntivia
11.12.1 Syntivia Company Details
11.12.2 Syntivia Business Overview
11.12.3 Syntivia Ex Vivo Skin Explants Introduction
11.12.4 Syntivia Revenue in Ex Vivo Skin Explants Business (2021–2026)
11.12.5 Syntivia Recent Development
11.13 Creative Biolabs
11.13.1 Creative Biolabs Company Details
11.13.2 Creative Biolabs Business Overview
11.13.3 Creative Biolabs Ex Vivo Skin Explants Introduction
11.13.4 Creative Biolabs Revenue in Ex Vivo Skin Explants Business (2021–2026)
11.13.5 Creative Biolabs Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.1.1 Research Programs/Design
13.1.1.2 Market Size Estimation
13.1.1.3 Market Breakdown and Data Triangulation
13.1.2 Data Source
13.1.2.1 Secondary Sources
13.1.2.2 Primary Sources
13.2 Author Details
13.3 Disclaimer
List of Tables
Table 1. Global Ex Vivo Skin Explants Market Size Growth Rate by Type (US$ Million): 2021 vs 2025 vs 2032
Table 2. Key Players of Human Skin Explants
Table 3. Key Players of Animal Skin Explants
Table 4. Global Ex Vivo Skin Explants Market Size Growth by Application (US$ Million): 2021 vs 2025 vs 2032
Table 5. Global Ex Vivo Skin Explants Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
Table 6. Global Ex Vivo Skin Explants Market Size by Region (US$ Million), 2021–2026
Table 7. Global Ex Vivo Skin Explants Market Share by Region (2021–2026)
Table 8. Global Ex Vivo Skin Explants Forecasted Market Size by Region (US$ Million), 2027–2032
Table 9. Global Ex Vivo Skin Explants Market Share by Region (2027–2032)
Table 10. Ex Vivo Skin Explants Market Trends
Table 11. Ex Vivo Skin Explants Market Drivers
Table 12. Ex Vivo Skin Explants Market Challenges
Table 13. Ex Vivo Skin Explants Market Restraints
Table 14. Global Ex Vivo Skin Explants Revenue by Players (US$ Million), 2021–2026
Table 15. Global Ex Vivo Skin Explants Market Share by Players (2021–2026)
Table 16. Global Top Ex Vivo Skin Explants Players by Tier (Tier 1, Tier 2, and Tier 3), based on Ex Vivo Skin Explants Revenue, 2025
Table 17. Ranking of Global Top Ex Vivo Skin Explants Companies by Revenue (US$ Million) in 2025
Table 18. Global 5 Largest Players Market Share by Ex Vivo Skin Explants Revenue (CR5 and HHI), 2021–2026
Table 19. Global Key Players of Ex Vivo Skin Explants, Headquarters and Area Served
Table 20. Global Key Players of Ex Vivo Skin Explants, Products and Applications
Table 21. Global Key Players of Ex Vivo Skin Explants, Date of General Availability (GA)
Table 22. Mergers and Acquisitions, Expansion Plans
Table 23. Global Ex Vivo Skin Explants Market Size by Type (US$ Million), 2021–2026
Table 24. Global Ex Vivo Skin Explants Revenue Market Share by Type (2021–2026)
Table 25. Global Ex Vivo Skin Explants Forecasted Market Size by Type (US$ Million), 2027–2032
Table 26. Global Ex Vivo Skin Explants Revenue Market Share by Type (2027–2032)
Table 27. Global Ex Vivo Skin Explants Market Size by Application (US$ Million), 2021–2026
Table 28. Global Ex Vivo Skin Explants Revenue Market Share by Application (2021–2026)
Table 29. Global Ex Vivo Skin Explants Forecasted Market Size by Application (US$ Million), 2027–2032
Table 30. Global Ex Vivo Skin Explants Revenue Market Share by Application (2027–2032)
Table 31. North America Ex Vivo Skin Explants Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 32. North America Ex Vivo Skin Explants Market Size by Country (US$ Million), 2021–2026
Table 33. North America Ex Vivo Skin Explants Market Size by Country (US$ Million), 2027–2032
Table 34. Europe Ex Vivo Skin Explants Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 35. Europe Ex Vivo Skin Explants Market Size by Country (US$ Million), 2021–2026
Table 36. Europe Ex Vivo Skin Explants Market Size by Country (US$ Million), 2027–2032
Table 37. Asia-Pacific Ex Vivo Skin Explants Market Size Growth Rate by Region (US$ Million): 2021 vs 2025 vs 2032
Table 38. Asia-Pacific Ex Vivo Skin Explants Market Size by Region (US$ Million), 2021–2026
Table 39. Asia-Pacific Ex Vivo Skin Explants Market Size by Region (US$ Million), 2027–2032
Table 40. Latin America Ex Vivo Skin Explants Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 41. Latin America Ex Vivo Skin Explants Market Size by Country (US$ Million), 2021–2026
Table 42. Latin America Ex Vivo Skin Explants Market Size by Country (US$ Million), 2027–2032
Table 43. Middle East & Africa Ex Vivo Skin Explants Market Size Growth Rate by Country (US$ Million): 2021 vs 2025 vs 2032
Table 44. Middle East & Africa Ex Vivo Skin Explants Market Size by Country (US$ Million), 2021–2026
Table 45. Middle East & Africa Ex Vivo Skin Explants Market Size by Country (US$ Million), 2027–2032
Table 46. Genoskin Company Details
Table 47. Genoskin Business Overview
Table 48. Genoskin Ex Vivo Skin Explants Product
Table 49. Genoskin Revenue in Ex Vivo Skin Explants Business (US$ Million), 2021–2026
Table 50. Genoskin Recent Development
Table 51. MatTek Life Sciences Company Details
Table 52. MatTek Life Sciences Business Overview
Table 53. MatTek Life Sciences Ex Vivo Skin Explants Product
Table 54. MatTek Life Sciences Revenue in Ex Vivo Skin Explants Business (US$ Million), 2021–2026
Table 55. MatTek Life Sciences Recent Development
Table 56. Creative Bioarray Company Details
Table 57. Creative Bioarray Business Overview
Table 58. Creative Bioarray Ex Vivo Skin Explants Product
Table 59. Creative Bioarray Revenue in Ex Vivo Skin Explants Business (US$ Million), 2021–2026
Table 60. Creative Bioarray Recent Development
Table 61. EpiSkin Company Details
Table 62. EpiSkin Business Overview
Table 63. EpiSkin Ex Vivo Skin Explants Product
Table 64. EpiSkin Revenue in Ex Vivo Skin Explants Business (US$ Million), 2021–2026
Table 65. EpiSkin Recent Development
Table 66. Reprocell Company Details
Table 67. Reprocell Business Overview
Table 68. Reprocell Ex Vivo Skin Explants Product
Table 69. Reprocell Revenue in Ex Vivo Skin Explants Business (US$ Million), 2021–2026
Table 70. Reprocell Recent Development
Table 71. Alcyomics Company Details
Table 72. Alcyomics Business Overview
Table 73. Alcyomics Ex Vivo Skin Explants Product
Table 74. Alcyomics Revenue in Ex Vivo Skin Explants Business (US$ Million), 2021–2026
Table 75. Alcyomics Recent Development
Table 76. Epistem Company Details
Table 77. Epistem Business Overview
Table 78. Epistem Ex Vivo Skin Explants Product
Table 79. Epistem Revenue in Ex Vivo Skin Explants Business (US$ Million), 2021–2026
Table 80. Epistem Recent Development
Table 81. QIMA Life Sciences Company Details
Table 82. QIMA Life Sciences Business Overview
Table 83. QIMA Life Sciences Ex Vivo Skin Explants Product
Table 84. QIMA Life Sciences Revenue in Ex Vivo Skin Explants Business (US$ Million), 2021–2026
Table 85. QIMA Life Sciences Recent Development
Table 86. Extherid Biosciences Company Details
Table 87. Extherid Biosciences Business Overview
Table 88. Extherid Biosciences Ex Vivo Skin Explants Product
Table 89. Extherid Biosciences Revenue in Ex Vivo Skin Explants Business (US$ Million), 2021–2026
Table 90. Extherid Biosciences Recent Development
Table 91. Perfectus Biomed Company Details
Table 92. Perfectus Biomed Business Overview
Table 93. Perfectus Biomed Ex Vivo Skin Explants Product
Table 94. Perfectus Biomed Revenue in Ex Vivo Skin Explants Business (US$ Million), 2021–2026
Table 95. Perfectus Biomed Recent Development
Table 96. Xenometrix Company Details
Table 97. Xenometrix Business Overview
Table 98. Xenometrix Ex Vivo Skin Explants Product
Table 99. Xenometrix Revenue in Ex Vivo Skin Explants Business (US$ Million), 2021–2026
Table 100. Xenometrix Recent Development
Table 101. Syntivia Company Details
Table 102. Syntivia Business Overview
Table 103. Syntivia Ex Vivo Skin Explants Product
Table 104. Syntivia Revenue in Ex Vivo Skin Explants Business (US$ Million), 2021–2026
Table 105. Syntivia Recent Development
Table 106. Creative Biolabs Company Details
Table 107. Creative Biolabs Business Overview
Table 108. Creative Biolabs Ex Vivo Skin Explants Product
Table 109. Creative Biolabs Revenue in Ex Vivo Skin Explants Business (US$ Million), 2021–2026
Table 110. Creative Biolabs Recent Development
Table 111. Research Programs/Design for This Report
Table 112. Key Data Information from Secondary Sources
Table 113. Key Data Information from Primary Sources
Table 114. Authors List of This Report


List of Figures
Figure 1. Ex Vivo Skin Explants Picture
Figure 2. Global Ex Vivo Skin Explants Market Size Comparison by Type (US$ Million), 2021–2032
Figure 3. Global Ex Vivo Skin Explants Market Share by Type: 2025 vs 2032
Figure 4. Human Skin Explants Features
Figure 5. Animal Skin Explants Features
Figure 6. Global Ex Vivo Skin Explants Market Size by Application (US$ Million), 2021–2032
Figure 7. Global Ex Vivo Skin Explants Market Share by Application: 2025 vs 2032
Figure 8. Pharmaceutical Case Studies
Figure 9. Cosmetic Case Studies
Figure 10. Others Case Studies
Figure 11. Ex Vivo Skin Explants Report Years Considered
Figure 12. Global Ex Vivo Skin Explants Market Size (US$ Million), Year-over-Year: 2021–2032
Figure 13. Global Ex Vivo Skin Explants Market Size, (US$ Million), 2021 vs 2025 vs 2032
Figure 14. Global Ex Vivo Skin Explants Market Share by Region: 2025 vs 2032
Figure 15. Global Ex Vivo Skin Explants Market Share by Players in 2025
Figure 16. Global Ex Vivo Skin Explants Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 17. The Top 10 and 5 Players Market Share by Ex Vivo Skin Explants Revenue in 2025
Figure 18. North America Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 19. North America Ex Vivo Skin Explants Market Share by Country (2021–2032)
Figure 20. United States Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 21. Canada Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 22. Europe Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 23. Europe Ex Vivo Skin Explants Market Share by Country (2021–2032)
Figure 24. Germany Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 25. France Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 26. U.K. Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 27. Italy Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 28. Russia Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 29. Ireland Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 30. Asia-Pacific Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 31. Asia-Pacific Ex Vivo Skin Explants Market Share by Region (2021–2032)
Figure 32. China Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 33. Japan Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 34. South Korea Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 35. Southeast Asia Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 36. India Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 37. Australia & New Zealand Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 38. Latin America Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 39. Latin America Ex Vivo Skin Explants Market Share by Country (2021–2032)
Figure 40. Mexico Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 41. Brazil Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 42. Middle East & Africa Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 43. Middle East & Africa Ex Vivo Skin Explants Market Share by Country (2021–2032)
Figure 44. Israel Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 45. Saudi Arabia Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 46. UAE Ex Vivo Skin Explants Market Size YoY Growth (US$ Million), 2021–2032
Figure 47. Genoskin Revenue Growth Rate in Ex Vivo Skin Explants Business (2021–2026)
Figure 48. MatTek Life Sciences Revenue Growth Rate in Ex Vivo Skin Explants Business (2021–2026)
Figure 49. Creative Bioarray Revenue Growth Rate in Ex Vivo Skin Explants Business (2021–2026)
Figure 50. EpiSkin Revenue Growth Rate in Ex Vivo Skin Explants Business (2021–2026)
Figure 51. Reprocell Revenue Growth Rate in Ex Vivo Skin Explants Business (2021–2026)
Figure 52. Alcyomics Revenue Growth Rate in Ex Vivo Skin Explants Business (2021–2026)
Figure 53. Epistem Revenue Growth Rate in Ex Vivo Skin Explants Business (2021–2026)
Figure 54. QIMA Life Sciences Revenue Growth Rate in Ex Vivo Skin Explants Business (2021–2026)
Figure 55. Extherid Biosciences Revenue Growth Rate in Ex Vivo Skin Explants Business (2021–2026)
Figure 56. Perfectus Biomed Revenue Growth Rate in Ex Vivo Skin Explants Business (2021–2026)
Figure 57. Xenometrix Revenue Growth Rate in Ex Vivo Skin Explants Business (2021–2026)
Figure 58. Syntivia Revenue Growth Rate in Ex Vivo Skin Explants Business (2021–2026)
Figure 59. Creative Biolabs Revenue Growth Rate in Ex Vivo Skin Explants Business (2021–2026)
Figure 60. Bottom-up and Top-down Approaches for This Report
Figure 61. Data Triangulation
Figure 62. Key Executives Interviewed
Choose Your Edition
Add to cart

Our team would be happy to assist you with your queries.

Contact us

About us

Accurate data, The latest market trends, And deeper research directions.

Our sole purpose is to provide a basis for leaders in all walks of life to make more appropriate decisions, to help companies solve existing problems and achieve business goals

Latest reports

Useful links

Our Contacts

Room 2306, T6 Fuxing World Financial Center, Kaifu District, Changsha, Hunan, China

(+86) 159 1069 5232

sales@hengceresearch.com
hengceresearch.com

Allow cookies